Pharmacies get a further £50m cash advance from Government

Latest

Pharmacies get a further £50m cash advance from Government

In Latest

Community pharmacies in England will receive a further £50m cash advance at the end of May to help keep the sector afloat amid severe cashflow worries.

The Pharmaceutical Services Negotiating Committee announced this afternoon that ministers had agreed to the cash injection, which is expected to be paid along with the NHS BSA payment on June 1 and follows a previous £300m cash advance for March and April.

PSNC said that as well as seeking immediate cashflow assistance it was pressing the Government to recognise the need for new funding outside the global sum provisions to help pharmacies cope during the Covid-19 crisis.

“This includes seeking to prevent contractors having to repay any of the advance payments that they have so far received this year,” a PSNC statement said, adding that a funding bid was currently being considered by HM Treasury,

PSNC is also continuing to work with other organisations to build an evidence base on the additional costs contractors have incurred since the pandemic hit Britain, and will shortly be submitting data for April to ministers.

Chief executive Simon Dukes said that since March PSNC has consistently highlighted the “urgent need for more investment in the sector to cover Covid-19 related costs”.

“Our requests for cashflow assistance have once again led to a cash injection and, combined with the £15m increase in medicines prices in June, this should help to ease some of the immediate cashflow and procurement pressures on businesses,” Mr Dukes said.

Advance ‘loads more debt’ onto sector

The National Pharmacy Association warned that while the advance will offer short-term relief it could ultimately “load more debt” onto pharmacies.

Commenting that pharmacists are “bearing a heavy financial burden in order to keep people safe and well,” NPA chief executive Mark Lyonette said: “Today’s announcement make talks on cost recovery even more urgent. We need assurances on the medium term position, because this new advance effectively increases the level of pharmacies’ debt to Government. Many independent pharmacies will struggle to pay it back and should never be asked to do so.

“This advance will make it easier for our members to pay their bills, for now, and to keep vital services going. But it isn’t new money and doesn’t get to the root of the funding problems.”

Royal Pharmaceutical Society England board chair Claire Anderson echoed these concerns and said the Government should shift its emphasis to a “fair funding settlement for the longer term”.

Ms Anderson said: “The ‘new normal’ for the NHS coping with COVID-19 will need a contract which makes the most of pharmacists’ clinical skills to support patients, improve medicines safety, and help people stay healthy and out of hospital.

“The NHS and Government now need to back pharmacy and build on the incredible work the profession during COVID-19 to support patient care.”

Record my learning outcomes

Latest

Inspiring stories related to health, fitness and the pursuit of wellbeing

Share:

More like this

bookmark_icon_off
Latest

Dudley pharmacies offer lateral flow Covid tests to public

Community pharmacies in Dudley are offering rapid lateral flow tests for Covid-19 to the public in the first scheme of its kind in the UK.

1 Min Article

bookmark_icon_off
Latest

Avicenna branches up for auction weeks after acquisition

Fifteen pharmacies in Wales that were acquired by Avicenna in April are to be sold at auction next week.

1 Min Article

bookmark_icon_off
Latest

NICE calls for greater use of community pharmacies

NICE is calling for the NHS to make greater use of community pharmacies to promote health and wellbeing in local areas.

1 Min Article

bookmark_icon_off
Latest

Mumps cases reach 10-year high

The rise in cases has been largely driven by outbreaks in universities and colleges.

1 Min Article

bookmark_icon_off
Latest

Experimental RSV drug ‘promising’ says MHRA

The MHRA has granted a ‘promising innovative medicine’ designation to experimental RSV drug nirsevimab. 

1 Min Article

bookmark_icon_off
Latest

And the winner is…

From purple hair and bake sales to local radio broadcasts and VIP visits, Pancreatic Cancer Action’s inaugural Turn it Purple! Pharmacy of the Year Award saw it all. But who came out on top?

1 Min Article

Recommended Learning

bookmark_icon_off
Sponsored education

Challenge your thinking on warts and verrucas

Discover different treatment options for warts and verruas and when to recommend them to your customers, based on their individual needs

17 Min Module

bookmark_icon_off
Videos

Advising on thrush treatment

This video looks at the distinctive benefits of different combination products and how to find the right treatment option for your customer.

7 Min Module

bookmark_icon_off
Sponsored education

Skincare training for pharmacy

Delve into dry skin management and understand how you can make a difference to customers looking for advice, support and product recommendations to help manage their compromised skin.

15 Min Module

bookmark_icon_off
Sponsored education

Managing heartburn and indigestion in the pharmacy

Learn how to identify and help customers manage heartburn and indigestion, from recommending the right products to ease symptoms, to self-care advice and identifying red flags for referral

10 Min Module

Bayer Business Programme

Retail ready: Building confidence in retail skills - Module

How to make the most of technology and the commercial opportunites it offers

10 Min Module

bookmark_icon_off
Sponsored education

Understanding constipation treatments

Discover the key benefits of different types of laxatives, and the right questions to ask customers to ensure you know which to recommend

10 Min Module